Assertio Holdings (ASRT) Appoints Mark Reisenauer to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. QGEN
9. SPCX
10. LRCX

Go back to Assertio Holdings (ASRT) Appoints Mark Reisenauer to its Board

Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors

December 17, 2024 8:30 AM EST

LAKE FOREST, Ill., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced today that Mark Reisenauer has been appointed as an independent director to the Companys Board of Directors. Mr. Reisenauer will serve as a member of the Compensation Committee.

Mark is a highly accomplished commercial leader in complex, competitive therapeutic areas who also brings extensive oncology and hematology product experience to our board, said Heather Mason, Chair of Assertio. His successful new product and... More